Everything we know about the woman who got sick and halted a promising coronavirus vaccine trial

[perugu_vada]

 

AstraZeneca halted its Phase 3 coronavirus vaccine trial earlier this week following a severe reaction that may or may not have been induced by the vaccine.

CEO Pascal Soriot addressed the matter in a private call with investors, explaining that a woman in the UK who received the vaccine candidate developed neurological issues. Her condition is improving, and she was expected to be discharged on Wednesday.

Reports earlier this week said the British woman might have developed a condition called transverse myelitis, and that researchers are looking at whether it could have been caused by the experimental vaccine.